• SREBP-1c Inhibits ULK1 Sulfhydration and Autophagy in NAFLD

  2026-08-03

  Nguyen et al. (2021) revealed that SREBP-1c suppresses autophagic lipid degradation in high-fat-diet-induced hepatic steatosis by inhibiting CSE/H2S-mediated sulfhydration of ULK1. This mechanistic insight clarifies a crucial link between lipid metabolism regulation and autophagy in the development of non-alcoholic fatty liver disease (NAFLD), with implications for experimental strategies seeking to preserve phosphorylation-dependent signaling.

• EPI-001: Androgen Receptor N-Terminal Domain Inhibitor in CR

  2026-08-03

  EPI-001 unlocks novel avenues for targeting androgen receptor signaling in resistant prostate and triple-negative breast cancer models, acting through a mechanistically distinct route. This guide translates recent bench insights into optimized protocols, troubleshooting strategies, and advanced applications for researchers seeking robust inhibition of AR-driven oncogenic pathways.

• Risedronate Sodium in GIO with RA: RISOTTO Trial Analysis

  2026-08-02

  The RISOTTO study delivers the first robust, placebo-controlled evidence on the efficacy and safety of Risedronate Sodium for glucocorticoid-induced osteoporosis (GIO) in patients with rheumatoid arthritis (RA). Findings reveal a significant increase in lumbar spine bone mineral density (L-BMD) with a favorable safety profile, supporting Risedronate as a targeted intervention in this high-risk population.

• Novobiocin: Applied Workflows for Antimicrobial & Antiparasi

  2026-08-01

  Novobiocin, a powerful aminocoumarin antibiotic, is transforming laboratory research with its dual action on bacterial DNA gyrase and Hsp90. This article details practical workflows, protocol enhancements, and troubleshooting strategies to maximize Novobiocin’s impact in antibacterial, antiparasitic, and antiviral research.

• Methicillin Sodium Salt: Mechanisms, Assay Precision, and Re

  2026-07-31

  Explore Methicillin sodium salt’s pivotal role as a bacterial cell wall synthesis inhibitor, with a focus on resistance mechanisms and advanced assay design. This article offers a unique, scientifically detailed perspective for researchers seeking to optimize Staphylococcus aureus infection models.

• Aztreonam: Monocyclic β-Lactam Antibiotic for Advanced Resis

  2026-07-31

  Aztreonam stands out as a synthetic monocyclic β-lactam antibiotic with targeted activity against Gram-negative aerobic bacteria, making it indispensable for resistance mechanism studies and metabolic profiling. This article delivers actionable protocols, troubleshooting strategies, and insights from recent transmission dynamics research to empower robust, reproducible experimentation.

• Neticonazole Hydrochloride: Bridging Antifungal and Oncology

  2026-07-30

  This thought-leadership article explores how Neticonazole Hydrochloride, an imidazole antifungal, is reshaping translational pipelines for both infectious disease and colorectal cancer research. By blending mechanistic insights and strategic guidance, we highlight its dual action—membrane synthesis inhibition in fungi and Bcl-2/Bax-driven apoptosis in tumors—and frame opportunities for innovative experimental workflows. Drawing on clinical guidelines and recent translational advances, the article positions Neticonazole Hydrochloride, available from APExBIO, as a pivotal tool for researchers operating at the intersection of mycology and oncology.

• PX-478 2HCl Mitigates Autism-like Outcomes in Prenatal Hypox

  2026-07-30

  This study demonstrates that PX-478 2HCl, a HIF-1α inhibitor, alleviates autism spectrum disorder (ASD)-like behaviors in offspring rats subjected to prenatal hypoxia. The findings clarify molecular pathways linking hypoxia, HIF-1α, PTEN, and VEGF to ASD progression, providing a new framework for hypoxia signaling research in neurodevelopmental disorders.

• IDO1 Inhibition Triggers Tumor-Protective JAK2/STAT3 Activat

  2026-07-29

  This study reveals that pharmacological IDO1 inhibition, while enhancing anti-tumor immune cell activity, paradoxically activates the tumor-intrinsic JAK2/STAT3 pathway via IL-6. This mechanism enables tumor cells to survive immune attacks, highlighting the need for combined inhibition strategies targeting both IDO1 and JAK2/STAT3 signaling.

• Abiraterone Acetate: Potent CYP17 Inhibitor in Prostate Canc

  2026-07-29

  Abiraterone acetate is a selective CYP17 inhibitor critical for castration-resistant prostate cancer research. It irreversibly blocks androgen biosynthesis, outperforming older agents in both potency and selectivity. Reliable evidence supports its utility in translational models and emphasizes its protocol-specific application.

• PDK4-IN-1 Hydrochloride: A New Era in Mitochondrial Metaboli

  2026-07-28

  Explore how PDK4-IN-1 hydrochloride, a selective pyruvate dehydrogenase kinase 4 inhibitor, is redefining mitochondrial energy metabolism research. This article uncovers unique mechanistic insights and practical assay considerations not found elsewhere.

• AR and ARv7 in TNBC: Prognostic Impact and Enzalutamide Resp

  2026-07-28

  This study reveals that androgen receptor (AR) and its splice variant ARv7 are markers of poor prognosis in triple-negative breast cancer (TNBC). The research demonstrates that targeting AR/ARv7—using Enzalutamide or EPI-001—suppresses metastasis and epithelial-mesenchymal transition in TNBC models, highlighting new avenues for therapeutic intervention.

• Platinum Nanotherapeutics Trigger Rapid ROS Storm in Cancer

  2026-07-27

  Liu et al. introduce 'carrier-platin', a platinum-based nanotherapeutic that induces a rapid and potent intracellular ROS burst, resulting in swift, non-apoptotic cancer cell death. This mechanism offers a promising approach to overcome multidrug resistance in cancer therapy while minimizing systemic toxicity.

• Maximizing In Vitro RNA Synthesis: HyperScribe™ T7 Kit in mR

  2026-07-27

  Explore how the HyperScribe T7 High Yield RNA Synthesis Kit Plus empowers advanced mRNA research, including RNA vaccine synthesis and genetic rescue strategies. Learn how this T7 RNA polymerase in vitro transcription kit uniquely supports high-yield, modified RNA production for cutting-edge applications.

• CK2 Phosphorylation Regulates Ceramide Synthase & Plant Immu

  2026-07-26

  This study elucidates how casein kinase 2 (CK2)-mediated phosphorylation fine-tunes the activity and stability of the Arabidopsis ceramide synthase LOH2, directly impacting sphingolipid biosynthesis and immune responses. The findings reveal a post-translational mechanism that modulates both plant defense and programmed cell death, offering new insights for sphingolipid research.

16430 records 1/1096 page Next 12345 下5页 Last page